The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Methicillin-Susceptible Staphylococcus Aureus Market Research Report 2025
Synopsis
Methicillin-susceptible staphylococcus aureus infections are caused by gram-positive bacterium, which leads to skin allergies, pneumonia and endocarditis.
The global Methicillin-Susceptible Staphylococcus Aureus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Methicillin-Susceptible Staphylococcus Aureus is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methicillin-Susceptible Staphylococcus Aureus is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Methicillin-Susceptible Staphylococcus Aureus in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Methicillin-Susceptible Staphylococcus Aureus include Dainippon Sumitomo Pharma Co., Ltd, Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG, Arsanis Biosciences GmbH, Volcano Corporation and Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methicillin-Susceptible Staphylococcus Aureus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methicillin-Susceptible Staphylococcus Aureus.
Report Scope
The Methicillin-Susceptible Staphylococcus Aureus market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methicillin-Susceptible Staphylococcus Aureus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methicillin-Susceptible Staphylococcus Aureus companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
AngioScore Inc.
Segment by Type
Cephalosporins
Vancomycin
Linezolid
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methicillin-Susceptible Staphylococcus Aureus companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Methicillin-susceptible staphylococcus aureus infections are caused by gram-positive bacterium, which leads to skin allergies, pneumonia and endocarditis.
The global Methicillin-Susceptible Staphylococcus Aureus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Methicillin-Susceptible Staphylococcus Aureus is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methicillin-Susceptible Staphylococcus Aureus is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Methicillin-Susceptible Staphylococcus Aureus in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Methicillin-Susceptible Staphylococcus Aureus include Dainippon Sumitomo Pharma Co., Ltd, Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG, Arsanis Biosciences GmbH, Volcano Corporation and Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methicillin-Susceptible Staphylococcus Aureus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methicillin-Susceptible Staphylococcus Aureus.
Report Scope
The Methicillin-Susceptible Staphylococcus Aureus market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methicillin-Susceptible Staphylococcus Aureus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methicillin-Susceptible Staphylococcus Aureus companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
AngioScore Inc.
Segment by Type
Cephalosporins
Vancomycin
Linezolid
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methicillin-Susceptible Staphylococcus Aureus companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cephalosporins
1.2.3 Vancomycin
1.2.4 Linezolid
1.2.5 Others
1.3 Market by Application
1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2019-2030)
2.2 Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Region
2.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Region (2019-2024)
2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Region (2025-2030)
2.3 Methicillin-Susceptible Staphylococcus Aureus Market Dynamics
2.3.1 Methicillin-Susceptible Staphylococcus Aureus Industry Trends
2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2019-2024)
3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2019-2024)
3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2023
3.5 Methicillin-Susceptible Staphylococcus Aureus Key Players Head office and Area Served
3.6 Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
3.7 Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Type
4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Type (2019-2024)
4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2025-2030)
5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Application
5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Application (2019-2024)
5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2019-2030)
6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024)
6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2019-2030)
7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024)
7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2019-2030)
8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2019-2024)
8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2019-2030)
9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024)
9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2019-2030)
10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024)
10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dainippon Sumitomo Pharma Co., Ltd
11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Detail
11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
11.2 Immtech Pharmaceuticals, Inc.
11.2.1 Immtech Pharmaceuticals, Inc. Company Detail
11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
11.3 Lytix Biopharma AS
11.3.1 Lytix Biopharma AS Company Detail
11.3.2 Lytix Biopharma AS Business Overview
11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.3.5 Lytix Biopharma AS Recent Development
11.4 PharmaIN Corporation
11.4.1 PharmaIN Corporation Company Detail
11.4.2 PharmaIN Corporation Business Overview
11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.4.5 PharmaIN Corporation Recent Development
11.5 Cubist Pharmaceuticals
11.5.1 Cubist Pharmaceuticals Company Detail
11.5.2 Cubist Pharmaceuticals Business Overview
11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.5.5 Cubist Pharmaceuticals Recent Development
11.6 Kenta Biotech AG
11.6.1 Kenta Biotech AG Company Detail
11.6.2 Kenta Biotech AG Business Overview
11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.6.5 Kenta Biotech AG Recent Development
11.7 Arsanis Biosciences GmbH
11.7.1 Arsanis Biosciences GmbH Company Detail
11.7.2 Arsanis Biosciences GmbH Business Overview
11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.7.5 Arsanis Biosciences GmbH Recent Development
11.8 Volcano Corporation
11.8.1 Volcano Corporation Company Detail
11.8.2 Volcano Corporation Business Overview
11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.8.5 Volcano Corporation Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.9.5 Abbott Laboratories Recent Development
11.10 AngioScore Inc.
11.10.1 AngioScore Inc. Company Detail
11.10.2 AngioScore Inc. Business Overview
11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
11.10.5 AngioScore Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cephalosporins
Table 3. Key Players of Vancomycin
Table 4. Key Players of Linezolid
Table 5. Key Players of Others
Table 6. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2019-2024)
Table 10. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2025-2030)
Table 12. Methicillin-Susceptible Staphylococcus Aureus Market Trends
Table 13. Methicillin-Susceptible Staphylococcus Aureus Market Drivers
Table 14. Methicillin-Susceptible Staphylococcus Aureus Market Challenges
Table 15. Methicillin-Susceptible Staphylococcus Aureus Market Restraints
Table 16. Global Methicillin-Susceptible Staphylococcus Aureus Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players (2019-2024)
Table 18. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2023)
Table 19. Ranking of Global Top Methicillin-Susceptible Staphylococcus Aureus Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
Table 23. Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2019-2024)
Table 27. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2025-2030)
Table 29. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Application (2019-2024)
Table 31. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Application (2025-2030)
Table 33. North America Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2025-2030) & (US$ Million)
Table 48. Dainippon Sumitomo Pharma Co., Ltd Company Detail
Table 49. Dainippon Sumitomo Pharma Co., Ltd Business Overview
Table 50. Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Product
Table 51. Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 52. Dainippon Sumitomo Pharma Co., Ltd Recent Development
Table 53. Immtech Pharmaceuticals, Inc. Company Detail
Table 54. Immtech Pharmaceuticals, Inc. Business Overview
Table 55. Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Product
Table 56. Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 57. Immtech Pharmaceuticals, Inc. Recent Development
Table 58. Lytix Biopharma AS Company Detail
Table 59. Lytix Biopharma AS Business Overview
Table 60. Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Product
Table 61. Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 62. Lytix Biopharma AS Recent Development
Table 63. PharmaIN Corporation Company Detail
Table 64. PharmaIN Corporation Business Overview
Table 65. PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Product
Table 66. PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 67. PharmaIN Corporation Recent Development
Table 68. Cubist Pharmaceuticals Company Detail
Table 69. Cubist Pharmaceuticals Business Overview
Table 70. Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Product
Table 71. Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 72. Cubist Pharmaceuticals Recent Development
Table 73. Kenta Biotech AG Company Detail
Table 74. Kenta Biotech AG Business Overview
Table 75. Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Product
Table 76. Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 77. Kenta Biotech AG Recent Development
Table 78. Arsanis Biosciences GmbH Company Detail
Table 79. Arsanis Biosciences GmbH Business Overview
Table 80. Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Product
Table 81. Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 82. Arsanis Biosciences GmbH Recent Development
Table 83. Volcano Corporation Company Detail
Table 84. Volcano Corporation Business Overview
Table 85. Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Product
Table 86. Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 87. Volcano Corporation Recent Development
Table 88. Abbott Laboratories Company Detail
Table 89. Abbott Laboratories Business Overview
Table 90. Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Product
Table 91. Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 92. Abbott Laboratories Recent Development
Table 93. AngioScore Inc. Company Detail
Table 94. AngioScore Inc. Business Overview
Table 95. AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Product
Table 96. AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024) & (US$ Million)
Table 97. AngioScore Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Type: 2023 VS 2030
Figure 3. Cephalosporins Features
Figure 4. Vancomycin Features
Figure 5. Linezolid Features
Figure 6. Others Features
Figure 7. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Methicillin-Susceptible Staphylococcus Aureus Report Years Considered
Figure 13. Global Methicillin-Susceptible Staphylococcus Aureus Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Methicillin-Susceptible Staphylococcus Aureus Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Region: 2023 VS 2030
Figure 16. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players in 2023
Figure 17. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2023
Figure 19. North America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2019-2030)
Figure 21. United States Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2019-2030)
Figure 25. Germany Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2019-2030)
Figure 33. China Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2019-2030)
Figure 41. Mexico Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2019-2030)
Figure 45. Turkey Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Dainippon Sumitomo Pharma Co., Ltd Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 48. Immtech Pharmaceuticals, Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 49. Lytix Biopharma AS Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 50. PharmaIN Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 51. Cubist Pharmaceuticals Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 52. Kenta Biotech AG Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 53. Arsanis Biosciences GmbH Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 54. Volcano Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 55. Abbott Laboratories Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 56. AngioScore Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
